Log in
Enquire now
‌

US Patent 11584961 Biomarkers for inflammatory skin disease

Patent 11584961 was granted and assigned to Incyte on February, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

TimelineTable: Further ResourcesReferences
Is a
Patent
Patent
1

Patent attributes

Patent Applicant
Incyte
Incyte
1
Current Assignee
Incyte
Incyte
1
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
115849611
Date of Patent
February 21, 2023
1
Patent Application Number
163697241
Date Filed
March 29, 2019
1
Patent Citations
‌
US Patent 10166191 Sustained-release dosage forms of ruxolitinib
‌
US Patent 11324749 Combination therapy for treatment of hematological diseases
1
Patent Primary Examiner
‌
Jehanne S Sitton
1
CPC Code
‌
C12Q 1/68
1

Biomarkers are provided that are predictive of a subject's responsiveness to a therapy comprising a JAK inhibitor. The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for a subject having, suspected of having, or at risk of developing an inflammatory skin disease.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11584961 Biomarkers for inflammatory skin disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.